Armenia vs Slovakia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Armenia
96.0%
in 2025
Slovakia
96.0%
in 2025
Armenia rank
27th
Slovakia rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Armenia
- Slovakia
How they compare
Armenia currently reports 96.0% against 96.0% in Slovakia, a difference of 0.0%.
Across all 18 years both countries report, Slovakia has been ahead every year.
Armenia ranks 27th and Slovakia ranks 27th of 194 countries.
Slovakia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Armenia | Slovakia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 49.5% | 49.5% | Slovakia |
| 2010s | 41.6% | 97.3% | 55.7% | Slovakia |
| 2020s | 93.7% | 96.2% | 2.5% | Slovakia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Armenia or Slovakia?
- Armenia, at 96.0% against 96.0% in Slovakia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Armenia and Slovakia?
- 0.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Slovakia?
- 18 years are reported by both, from 2008 to 2025.
- How do Armenia and Slovakia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Armenia ranks 27th and Slovakia ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.